Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance Article

publication date

  • April 25, 2022

webpage

published in

keywords

  • active surveillance
  • adverse pathology
  • germline mutations
  • prostate cancer